Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Multiple Myeloma 14Leukemia, Myeloid, Acute 13Lymphoma 12Neoplasm Metastasis 11Pancreatic Neoplasms 9Prostatic Neoplasms 8Myelodysplastic Syndromes 8Burkitt Lymphoma 8Breast Neoplasms 8Glioma 7Colorectal Neoplasms 7Sarcoma 6Leukemia, Lymphocytic, Chronic, B-Cell 6Triple Negative Breast Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 5Lymphoma, T-Cell 5Lymphoma, Non-Hodgkin 5Central Nervous System Neoplasms 5Carcinoma, Renal Cell 5Wilms Tumor 4Squamous Cell Carcinoma of Head and Neck 4Rhabdoid Tumor 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Lung Neoplasms 4Histiocytosis, Langerhans-Cell 4Hepatoblastoma 4

Interventions

Cisplatin 4Radiotherapy 3Cetuximab 3pembrolizumab 2Surveys and Questionnaires 2Carboplatin 2olaparib 1niraparib 1fludarabine 1dostarlimab 1cemiplimab 1calcipotriene 1avelumab 1atezolizumab 1aldesleukin 1Watchful Waiting 1Tiragolumab 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Platinum 1Phlebotomy 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Fluorouracil 1Fluorodeoxyglucose F18 1Docetaxel 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Biopsy × 30 days × Clear all
NCT03952585 2026-06-01

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
384 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡